Concepedia

Author

M. Walraven

Amsterdam UMC Location Vrije Universiteit AmsterdamORCID

Also Known As

M Walraven, M. Walraven, Marielle Walraven, Mariëlle Walraven

14

Publications

679

Citations

10

H-Index

52

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit AmsterdamAssociation of Dutch Burn CentresUniversity Medical Center UtrechtThe Netherlands Cancer InstituteUniversity Hospital Heidelberg
MW

About

M. Walraven is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, cell biology, and fibrosis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

367

2

Engineering

2

2

187

3

Natural Sciences

1

1

93

4

Public Health

1

1

43

5

Biochemistry

1

1

93

M. Walraven

×

8

Publications

423

Citations

8

H-Index

YearCitations

The fibronectin ED-A domain enhances recruitment of latent TGF-β-binding protein-1 to the fibroblast matrix

Franco Klingberg, Grace Chau, M. Walraven,

Journal of Cell Science

2018

164

Simple and selective method for the determination of various tyrosine kinase inhibitors used in the clinical setting by liquid chromatography tandem mass spectrometry

Richard J. Honeywell, K. Yarzadah, Elisa Giovannetti,

Journal of Chromatography B

2010

93

Healthy human second‐trimester fetal skin is deficient in leukocytes and associated homing chemokines

M. Walraven, Wendy Talhout, Robert H.J. Beelen,

Wound Repair and Regeneration

2016

43

Tissue Engineered Tubular Construct for Urinary Diversion in a Preclinical Porcine Model

Paul Geutjes, L.A.J. Roelofs, Henk R. Hoogenkamp,

The Journal of Urology

2012

39

Transforming growth factor-β (TGF-β) signaling in healthy human fetal skin: A descriptive study

M. Walraven, R.H.J. Beelen, Magda M. W. Ulrich

Journal of Dermatological Science

2015

27

In vitro cultured fetal fibroblasts have myofibroblast-associated characteristics and produce a fibrotic-like environment upon stimulation with TGF-β1: Is there a thin line between fetal scarless healing and fibrosis?

M. Walraven, Johanneke J. Akershoek, R.H.J. Beelen,

Archives of Dermatological Research

2016

23

Targeting the Endothelin Axis with Atrasentan, in combination with IFN-alpha, in metastatic renal cell carcinoma

Gerard Groenewegen, M. Walraven, Joost S.P. Vermaat,

British Journal of Cancer

2012

17

Symptoms from treatment with sunitinib or sorafenib: a multicenter explorative cohort study to explore the influence of patient-reported outcomes on therapy decisions

J.J. Koldenhof, Petronella O. Witteveen, Rien de Vos,

Supportive Care in Cancer

2014

17

Page 1